Sitagliptin Phosphate
시타글립틴인산염
KDMF APIs기타의 대사성 의약품KDMF 등록
품목명 (영문)
Sitagliptin Phosphate
품목명 (한글)
시타글립틴인산염
분류
기타의 대사성 의약품
CAS No.
654671-78-0
KDMF 등록번호
수5217-4-ND
제조원
Mylan Laboratories Limited(Unit-1)
규격
In-house
IUPAC Name
(3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one
Synonyms
Sitagliptin
Description
Sitagliptin is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor used in conjunction with diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus. The effect of this medication leads to glucose dependent increases in insulin and decreases in glucagon to improve control of blood sugar. Sitagliptin was granted FDA approval on October 16, 2006.
Certificate of Analysis
If you need more information, please contact us.
규격서·시험성적서 등 추가 자료가 필요하시면 문의 시 함께 요청해 주세요. 담당자가 확인 후 회신합니다. (02-579-1056 · ace@acebiopharm.com)
RELATED